India’s government is set to strengthen its export tax refund scheme by extending it for another five years and boosting funding. The move targets exporters hit by geopolitical strain linked to the Middle East crisis and rising shipping costs, aiming to keep trade flows resilient and help Indian companies compete globally despite higher logistical pressures.
India’s pharmaceutical exports fell 23.17% in March, a sharp reversal attributed to the West Asia conflict disrupting both shipping routes and air transit hubs. With Dubai and Abu Dhabi impacted, freight costs rose and losses are estimated at ₹2,500–₹5,000 crore. The hit threatens the smooth flow of essential medicines to global markets despite earlier FY26 growth.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
An Iran crisis is exposing a gap between “paper” oil prices and the cost of actually buying barrels. Futures markets price in expectations of eventual calm, but physical markets are reacting to immediate scarcity. Disrupted shipping and higher freight costs are inflating spot prices, creating big global disparities that traders and consumers feel right away.
Rising West Asia tensions are putting India’s energy and logistics system under stress. The risk is not only supply stoppages, but the ballooning of freight and insurance costs that can squeeze corporate margins and widen deficits. While strong balance sheets provide some protection, long volatility may pressure earnings, capex plans, and the credit cycle.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
